Bayer and Google Cloud announced a collaboration on the development of artificial intelligence (AI) solutions to support radiologists and ultimately better serve patients. As part of the collaboration, Bayer will further develop its innovation platform to accelerate the development and deployment of AI-powered healthcare applications with a clear focus on radiology, using Google Cloud's technology, including its generative AI (gen AI) tools.

North West Anglia NHS Foundation Trust has replaced two, legacy laboratory information systems with a single instance of Clinisys WinPath.

The trust, which serves a catchment of 800,000 patients in North Cambridgeshire and South Lincolnshire, found itself with two LIMS when it was formed out of the merger of Peterborough and Stamford Hospitals and Hinchingbrooke Health Care in 2017.

Alcidion Group Limited, a leading provider of FHIR-native patient flow solutions for healthcare, and Novari Health, a market leader in waitlist management and referral management technologies, have joined forces to offer a comprehensive approach to patient journey management.

Effective management of a patient’s journey requires a systemwide approach, from specialist referrals to inpatient admissions through to discharge. Key to this improvement is making data easily accessible and mobile, engaging clinicians, and predicting bottlenecks in the system.

Homerton Healthcare NHS Foundation Trust has become the first organisation anywhere in the NHS to deploy Sectra's enterprise imaging service using public cloud.

The deployment has shown that NHS patient imaging can be efficiently accessed from a secure public cloud environment, just as quickly as when data is stored on-premise.

A systemic cause of patient harm could be better avoided with the help of technology, following the launch of Miya Results Tracking by health tech company Alcidion.

The new digital solution is designed to reduce the risk of test results not being followed up. It has been built to help healthcare professionals in hospital settings to more easily visualise, prioritise and acknowledge high volumes of tests results generated for patients every day, and to take appropriate action in a timely manner.

Bayer moves ahead with advancements across its comprehensive Radiology portfolio as well as expanded offering in its digital business and services. The company announced that new clinical and pre-clinical data for gadoquatrane, Bayer's novel investigational macrocyclic gadolinium-based contrast agent currently in Phase III clinical development, will be presented at the 2024 European Congress of Radiology (ECR) - taking place from February 28 to March 3, 2024, in Vienna, Austria.

The trust's Oldham laboratory has completed technical go-live, with its Salford site also set to follow. Collectively the laboratories provide a wide range of general and specialist pathology services that support diagnoses for patients in the region. This includes one of the largest dermatology departments in the country, and gynaecology services that cover six hospitals.